Alabama Family Joins National Zofran Lawsuits

As the public becomes more aware of the controversy surrounding the anti-nausea drug Zofran and its potential to cause birth defects when taken by pregnant women, lawsuits against the manufacturer GlaxoSmithKline (GSK) have been flooding in. Now joining plaintiffs from several other states is a family from Alabama, alleging that Zofran caused severe developmental defects in a boy born in 2006.

shutterstock_120217189

The mother began taking Zofran during her pregnancy to treat her nausea and vomiting. In August the boy was born, and doctors realized that the boy had a high, narrow palate and extra digits. After a few weeks, doctors diagnosed the boy with a distended kidney and ureteral disorder, and within several months he was also diagnosed with a seizure disorder. Now, he is a special needs child with no capacity for speech. Genetic testing of the boy and his family found no evidence of hereditary conditions that could have caused his developmental disorders.

Zofran Is Not a Proper Morning Sickness Treatment

Every year, roughly one million women are prescribed Zofran to treat symptoms of morning sickness despite the fact that the drug has never been approved to treat pregnancy-related nausea and vomiting. Babies exposed to the drug in utero could face an increased likelihood of serious birth defects like cleft palate, heart problems and musculoskeletal deformities.

If you were prescribed Zofran during the first trimester of pregnancy and your baby suffered from birth injuries, you should know that litigation against GSK is in its early stages. Contact a birth injury lawyer as soon as possible to learn more about Zofran and how you can pursue legal action.

Farrell & PatelBirth Injury Law Firm



Tags: